🔎 Trials Near Me

Hjem › Blodcancer › Washington › Seattle

Blodcancer kliniske forsøg i Seattle, WA

18 studier for Blodcancer søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • og 1 flere
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

RekruttererFase 1/2
  • Fred Hutchinson Cancer Research Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06697184

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

RekruttererFase 3
  • Fred Hutchinson Cancer Research Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

RekruttererObservationsstudie
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Alle aldre · Alle køn · Opdateret 17. sep. 2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RekruttererFase 1
  • University of Washington, Seattle
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

RekruttererFrivillige med god helbredstilstand velkomne
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT04515810

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

RekruttererFase 2
  • Fred Hutchinson Cancer Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservationsstudie
  • Fred Hutchinson Cancer Research Center, Seattle
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

RekruttererFase 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05952804

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

RekruttererFase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Alder 18 til 75 · Alle køn · Opdateret 22. jun. 2026 · NCT03670966

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

RekruttererObservationsstudie
  • Seattle Childrens Hospital, Seattle
Op til 30 år · Alle køn · Opdateret 18. jun. 2026 · NCT06579469

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RekruttererFase 1/2
  • University of Washington Medical Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

RekruttererFase 2Frivillige med god helbredstilstand velkomne
  • Fred Hutchinson Cancer Centre, Seattle
Alder 2 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT06510699

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

RekruttererObservationsstudie
  • Swedish Cancer Institute, Seattle
Alder 18 og opefter · Alle køn · Opdateret 25. jun. 2025 · NCT05768269

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Rekrutterer
  • University of Washington, Seattle
Alder 18 og opefter · Alle køn · Opdateret 20. apr. 2025 · NCT05956457

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

RekruttererFase 1
  • Fred Hutchinson Cancer Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekruttererFase 1
  • Seattle Children's Hospital, Seattle
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

RekruttererFase 1
  • Fred Hutchinson Cancer Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 15. nov. 2024 · NCT06034275

Blodcancer forsøg i andre byer

Andre studier i Seattle

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.